Takeda Pharmaceutical logo
Home
Facebook
Twitter
Linkedin
Summary:
COMPANY:​
Takeda Pharmaceutical
INDUSTRIES:​
Biotechnology, Health Care, Health Diagnostics, Medical, Pharmaceutical
HEADQUARTERS:​
Osaka, Osaka, Japan
ABOUT:
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company in Japan.
STOCK SYMBOL:
4502: TYO – Tokyo Stock Exchange
IPO STATUS:
Public
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company in Japan. The company markets its original products, such as the anti-prostatic cancer agent leuprolide acetate (marketed as Lupron Depot, Enantone, Prostap, and Leuplin), the anti-peptic ulcer agent lansoprazole (marketed as Prevacid, Ogast, Takepron, and other names), the anti-hypertensive agent candesartan cilexetil (marketed as Blopress, Kenzen, and Amias), and the anti-diabetic agent pioglitazone hydrochloride (marketed as Actos). Segments The company operates its business in two categories, Pharmaceutical business and Other businesses. The Pharmaceutical business represents the ethical drug business and healthcare business. Other businesses include business activities involving the production and marketing of a range of products, including vitamin bulks, test reagents & clinical diagnostics, photographic chemicals, and inorganic chemicals.
POWERED BY CRUNCHBASE
Financials:
FUNDING (USD):​
USD
STATUS:
For Profit
INVESTORS:​
57800000
TOP 5 INVESTORS:​
1
FOUNDERS:​
Chobei Takeda I
LAST LEADERSHIP HIRE:
Bill & Melinda Gates Foundation
EMPLOYEES:
10001+
ACQUISITIONS​:
Bill & Melinda Gates Foundation

YouTube

Takeda

Takeda is a patient-centric, science-driven global biopharmaceutical company that has strong, long-established values. Founded in Osaka, Japan, in 1781, we have always been and will always be unwavering in our commitment to bring better health and a brighter future to people worldwide.

The Takeda YouTube Channel is a place to find out more about what we do, keep up-to-date with our latest news, projects, and programs, and follow us on our mission to continue contributing to the health of patients worldwide.

Please see our Social Media Community Guidelines at https://www.takeda.com/newsroom/social-media/.

Notice:
Shire plc became part of Takeda on January 8th 2019.
About Takeda: https://www.takeda.com

Takeda
Listen to our Grange Castle, Ireland, team and what they have to say about the work culture at Takeda. Watch until the end. It will put a smile on your face.
An exceptional experience at Takeda
YouTube Video UCOaSrsYBpIQSxnW7badEtDg_fJS3oaKtQRg
Hear Demie’s story and how Takeda’s Patient Assistance Program ensured she received the treatment she needed for Hodgkin lymphoma and returned to College.
Meet the Patient: Demie R. Sastre
YouTube Video UCOaSrsYBpIQSxnW7badEtDg_HqP8RnEt7JQ
Follow Krishnan on his journey with chronic myeloid leukemia, and how treatment through Takeda's Patient Assistance Program and The Max Foundation helped him regain precious moments with his family.
Meet the Patient: Krishnan Kumar Gupta
YouTube Video UCOaSrsYBpIQSxnW7badEtDg_m1dzf3SkeCs
Hypoparatyreóza je vzácné endokrinní onemocnění způsobené nedostatkem parathormonu (PTH) v krvi. V tomto krátkém, animovaném videu se dozvíte, jak hypoparatyreóza vzniká, jak se projevuje, jak je diagnostikována a jaký má dopad na život pacientů. Více informací o hypoparatyreóze můžete najít na internetových stránkách https://bit.ly/2Yj4Ywu. Tyto informace jsou přístupné veřejnosti pouze pro informační účely. Účelem není nahradit odbornou lékařskou konzultaci nebo pomoc. V případě dotazů kontaktujte svého ošetřujícího lékaře. Vyrobeno a financováno společností Takeda. ©2020 Takeda Pharmaceuticals Czech Republic s.r.o.. Všechna práva vyhrazena. Takeda a logo Takeda jsou ochranné známky společnosti Takeda Pharmaceutical Company Limited používané na základě licence.
Vzácné onemocnění - HYPOPARATYREÓZA
YouTube Video UCOaSrsYBpIQSxnW7badEtDg_WjZ_Q12eQQ4
アジアNCEプロダクション研究所長を務める一川隆史は、コロナ禍に対して、「人間の過去の歴史を考えても、やはり進化できる方が強い」と、ポジティブに捉えています。 どのような状況にあっても、タケダに入社した時からのモチベーションである、医療に貢献したい、特に病気で苦しんでいる患者さんに新薬を提供したいという思いを持ち続け、それがあれば仕事への気持ちは変わらない、と一川は言います。「誰も経験したことのない状況」の中で、最初は戸惑いや焦りを感じたチームも、CROパートナーなどの協力を得て、優先順位を決め、進められるプロジェクトに集中したという。また、在宅勤務をきっかけに仕事のやり方などを見直し、リモートの中でも貢献できることをやっていきたいという思いもモチベーションになる、と前向きな姿勢を見せています。 タケダの研究員は、一川のように、皆、変則的な勤務状況の中でも創薬のための研究活動を止めることなく前に進もうとしています。彼らの創薬に対する強い想いが、タケダにとって、前進のためのエンジンです。 （本動画に出演している社員の肩書、業務内容は2020年6月撮影時のものです）
一川隆史：タケダR&D 科学と情熱
YouTube Video UCOaSrsYBpIQSxnW7badEtDg_D5GKUtbwBIQ
Load More... Subscribe

Twitter:

Takeda
Takeda

Thank you to Rachel, Beverley, Johan, Swapna and Durhane for sharing your stories of #RareStarResilience – and than… https://t.co/4GhkbQP29s

Takeda
Takeda

This #RareDiseaseDay we spoke with Durhane, president & CEO of @raredisorders and mother of children with rare dis… https://t.co/BQ0HSRqAOM

Takeda
Takeda

In honor of #RareDiseaseDay we spoke with Swapna, a #shortbowelsyndrome patient and advocate, and discussed the res… https://t.co/8UHQ3EmToB

Takeda
Takeda

In celebration of #RareDiseaseDay we spoke to @ipopi_info Executive Director @JohanPrevot to discuss the impact of… https://t.co/OvX9jSQV08

Takeda
Takeda

Today, on #RareDiseaseDay, Takeda is recognizing the resilience of the #raredisease community. Follow along as we s… https://t.co/TxA2Tj9JpI

Takeda
Takeda

Hoy y todos los días, acompañamos a la comunidad de pacientes con Enfermedades Raras. #RareDiseaseDay… https://t.co/pfqd9nfZuh

Tokyo Office:

2-chōme-1-1 Nihonbashihonchō, Chuo City, Tokyo 103-0023

Tagged